EVOLVEIMMUNE THERAPEUTICS
EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generate first-in-class treatments for unmet needs in oncology and autoimmune diseases.
EVOLVEIMMUNE THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Westport, Connecticut, United States
Country:
United States
Website Url:
http://www.evolveimmune.com
Total Employee:
1+
Status:
Active
Contact:
+1 203 858 7389
Email Addresses:
[email protected]
Total Funding:
17.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Raze Therapeutics
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Current Employees Featured
Founder
Investors List
Elm Street Ventures
Elm Street Ventures investment in Venture Round - EvolveImmune Therapeutics
Takeda Ventures
Takeda Ventures investment in Venture Round - EvolveImmune Therapeutics
Pfizer
Pfizer investment in Venture Round - EvolveImmune Therapeutics
Solasta Ventures
Solasta Ventures investment in Venture Round - EvolveImmune Therapeutics
Yonjin Venture
Yonjin Venture investment in Venture Round - EvolveImmune Therapeutics
Official Site Inspections
http://www.evolveimmune.com
- Host name: 183.206.174.34.bc.googleusercontent.com
- IP address: 34.174.206.183
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
